Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
While Semaglutide is powerful, weight loss is never just about one factor
In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
They reflect the actual structure of the platform and represent a meaningful departure from competitors that bury ongoing charges in fine print
Other health benefits to expect: Now that so many people have taken Ozempic and other weight loss medications for long periods, we know very well what the overall health benefits are
![glp-1 agonist drug list of glp 1 agonists current and its analogs [36-39] glp 1 names list Types of GLP-1 Medications for –](https://www.researchgate.net/publication/371322849/figure/tbl1/AS:11431281165596278@1686056417230/List-of-current-GLP-1-and-its-analogs-36-39.png)
